Main findings
This randomized, single-center, open-label trial was launched to explore
whether full ERAS perioperative management would improve surgical
outcomes in patients undergoing simple gynaecologic laparoscopic
procedures compared with a limited ERAS program. Our study showed that
the full ERAS pathway further improved patient outcome by shortening the
length of stay, reducing postoperative pain, reducing narcotics
consumption, and improving the quality of life—while not compromising
morbidity or the readmission rate within 30 days after surgery.